These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 10115576)

  • 1. Timeliness of receipt of manufacturers' new product information.
    Murdoch LA; Lum L
    Can J Hosp Pharm; 1991 Oct; 44(5):235-8. PubMed ID: 10115576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The PMAC code of marketing practices: time for improvement? Pharmaceutical Manufacturers Association of Canada.
    Desjardins JG
    CMAJ; 1997 Feb; 156(3):363-4. PubMed ID: 9033417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peer review quality assurance program in drug information.
    Tierney M; Godbout L; Repchinsky C
    Can J Hosp Pharm; 1991 Feb; 44(1):31-4. PubMed ID: 10110041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cross-sectional evidence-based review of pharmaceutical promotional marketing brochures and their underlying studies: is what they tell us important and true?
    Cardarelli R; Licciardone JC; Taylor LG
    BMC Fam Pract; 2006 Mar; 7():13. PubMed ID: 16515686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs in the news: an analysis of Canadian newspaper coverage of new prescription drugs.
    Cassels A; Hughes MA; Cole C; Mintzes B; Lexchin J; McCormack JP
    CMAJ; 2003 Apr; 168(9):1133-7. PubMed ID: 12719316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of a pharmacist on the educational value of pharmaceutical industry film showings.
    Bayliff CD; Edington RD; Johnston LJ; Shaw PW; Bailey DG
    Can J Hosp Pharm; 1991 Dec; 44(6):283-7. PubMed ID: 10116487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Food and Drug Administration surveillance of dermatology-related and nondermatology-related prescription drug advertising in the USA, 2000-2003.
    Cowden AL; Katz KA
    Br J Dermatol; 2006 May; 154(5):950-8. PubMed ID: 16634900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National addictions vigilance intervention and prevention program (NAVIPPRO): a real-time, product-specific, public health surveillance system for monitoring prescription drug abuse.
    Butler SF; Budman SH; Licari A; Cassidy TA; Lioy K; Dickinson J; Brownstein JS; Benneyan JC; Green TC; Katz N
    Pharmacoepidemiol Drug Saf; 2008 Dec; 17(12):1142-54. PubMed ID: 18932173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Critical evaluation of the claims made by pharmaceutical companies in drug promotional material in Pakistan.
    Rohra DK; Gilani AH; Memon IK; Perven G; Khan MT; Zafar H; Kumar R
    J Pharm Pharm Sci; 2006; 9(1):50-9. PubMed ID: 16849008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prescription data.
    Zitner D
    CMAJ; 2001 May; 164(10):1408-9; author reply 1409-10. PubMed ID: 11387909
    [No Abstract]   [Full Text] [Related]  

  • 12. Have you seen the new CSHP-PMAC product information form?
    Naylor MJ
    Can J Hosp Pharm; 1979; 32(3):79. PubMed ID: 10242859
    [No Abstract]   [Full Text] [Related]  

  • 13. "But doctors do it...": nurses' views of gifts and information from the pharmaceutical industry.
    Jutel A; Menkes DB
    Ann Pharmacother; 2009 Jun; 43(6):1057-63. PubMed ID: 19470854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guidelines for pharmacists and the pharmaceutical industry. The Canadian Society of Hospital Pharmacists.
    Dimens Health Serv; 1990 Nov; 67(8):14-6. PubMed ID: 2276520
    [No Abstract]   [Full Text] [Related]  

  • 15. An assessment of direct-to-consumer advertising of prescription drugs.
    Calfee JE
    Clin Pharmacol Ther; 2007 Oct; 82(4):357-60. PubMed ID: 17851572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Agents against pediatric diarrhea. Assessing the information companies supply to Canadian physicians.
    Lexchin J
    Can Fam Physician; 1994 Dec; 40():2082-7. PubMed ID: 7888820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy versus practice: comparison of prescribing therapy and durable medical equipment in medical and educational settings.
    Sneed RC; May WL; Stencel C
    Pediatrics; 2004 Nov; 114(5):e612-25. PubMed ID: 15520092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of drug information service provided by pharmaceutical manufacturers.
    Doyal LE
    Am J Hosp Pharm; 1990 May; 47(5):1014. PubMed ID: 2337090
    [No Abstract]   [Full Text] [Related]  

  • 19. Code of marketing practices. Voluntary self-regulation for the Pharmaceutical Manufacturers Association of Canada.
    Lexchin J
    Can Fam Physician; 1997 Nov; 43():1997. PubMed ID: 9386886
    [No Abstract]   [Full Text] [Related]  

  • 20. PMAC code of marketing practices.
    Lexchin J
    CMAJ; 1999 Jun; 160(11):1556. PubMed ID: 10447368
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.